Locally Recurrent Skin Squamous Cell Carcinoma
1 clinical trials · Condition
◉ Watch Locally Recurrent Skin Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System (NCT07042295) | National Cancer Institute (NCI) | 2026-03-23 |
Track Locally Recurrent Skin Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.